Author Archives: Lu Rahman

#Covid-19 #Drug discovery #Therapeutics

New flu therapy may help against COVID-19

A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists. In an average year, more than 2 million people in the United States are hospitalised with the flu, and 30,000 to… Read More

#Covid-19 #News

#AI / data analytics / healthtech / informatics #Drug discovery

Biosero and TetraScience R&D data update accelerates drug discovery

Biosero and TetraScience have revealed that they will integrate data glyphs, instruments and robotic sensors with the cloud-native Tetra Data Platform using Green Button Go Automation Scheduling Software. Together the systems will automatically collect, store and harmonize life science R&D data in the cloud to accelerate drug discovery and research. Read More

#News

#Analysis #Bioanalytics

Creoptix and Oneservice partner for after-sales support

Creoptix, an expert in next-generation bioanalytical instrumentation has signed an agreement with Oneservice, a global provider of specialty technical services, to offer after-sales support and services for its ground-breaking WAVEsystem in Europe and the US. Creoptix’ WAVEsystem is a label-free biosensor used in life sciences research to study molecular interactions… Read More

#News

#Antibodies #Therapeutics

FairJourney Biologics enters antibody discovery agreement with Pandion Therapeutics

FairJourney Biologics and IONTAS have signed an agreement to discover antibodies with Pandion Therapeutics (Pandion). The partnership will harness both FJB and IONTAS’ proprietary antibody libraries and technology platforms to investigate novel therapeutic targets for autoimmune and inflammatory diseases. Pandion focuses on the development of innovative modular therapeutics using its… Read More

#News

#Assay development & optimisation #Drug discovery

Pharmacology expert explains how to improve the drug discovery process

In an exclusive event for DDW, Dr Holliday, Chief Scientific Officer, Excellerate Bioscience, will focus on the importance of kinetic assays in drug discovery. What you will learn: How association and dissociation rate constants describe compound binding kinetics The potential clinical benefits of optimising kinetic constants when compound profiling The… Read More

#News

#Business #Clinical trials #Therapeutics

Drug launches to drive NASH growth across major markets, says research

Several pharmacological treatments for non-alcoholic steatohepatitis (NASH) are expected to be launched in the seven major markets (7MM*) over the next 10 years. It is anticipated that these products can demand higher prices than the current off-label therapies, considering no therapy has been approved for the indication, and drive strong… Read More

#News #Trends & Analysis

#Covid-19 #Pharmaceutical #Research & development

UK pharma sector R&D spending at 8-year high

R&D spending in the UK pharmaceutical sector has jumped 6.9% annually to an eight-year high, analysis of the latest ONS data by R&D tax relief specialist Catax shows. Total pharmaceutical industry spending on R&D rose to £4.8bn last year, an increase of £306m from the £4.5bn recorded a year earlier1. Read More

#Editor's Choice #News #Trends & Analysis

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Oxford COVID-19 vaccine 70% effective

The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection. Following the trial reaching the target for interim analysis, the independent Data… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Cellular diagnostics #Therapeutics

Biofriendly protocells pump up blood vessels

An international team comprising researchers from the University of Bristol, and Hunan and Central South Universities in China, have prepared biocompatible protocells that generate nitric oxide gas – a known reagent for blood vessel dilation – that when placed inside blood vessels expand the biological tissue. In a new study… Read More

#News

#AI / data analytics / healthtech / informatics #Covid-19

Collaborative AI effort unravelling SARS-CoV-2 mysteries wins prestigious prize

The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the US Department of Energy’s (DOE) Argonne National Laboratory. The team was singled out for its work, ​AI-Driven Multiscale Simulations Illuminate Mechanisms of… Read More

#Covid-19 #News

#Clinical trials #Immunology / Virology & Vaccines

New study indicates Ebola vaccine safe, and produces robust immune response

Scientists from the University of Oxford, working as part of the EBOVAC2 EBL2001 study group, have announced the results of a Phase II trial of a replication-deficient adenovirus vaccine aimed at providing protection against the lethal Ebola virus. Writing in the journal Lancet: Infectious Diseases, they conclude that the two-dose… Read More

#News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Oxford coronavirus vaccine produces strong immune response in older adults

The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The data, published today in The Lancet, suggest that one of the groups most vulnerable to serious… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Imaging

MOBILion awarded grant to resolve biomarkers for Parkinson’s

MOBILion Systems is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of Parkinson’s disease (PD). The project is funded by a grant from The Michael J. Fox Foundation and its partner… Read More

#News